Claritas Pharmaceuticals Inc banner
C

Claritas Pharmaceuticals Inc
XTSX:CLAS

Watchlist Manager
Claritas Pharmaceuticals Inc
XTSX:CLAS
Watchlist
Price: 0.295 CAD Market Closed
Market Cap: CA$10.4m

Claritas Pharmaceuticals Inc
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Claritas Pharmaceuticals Inc
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
C
Claritas Pharmaceuticals Inc
XTSX:CLAS
Other Items
$2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Other Items
-$18.8B
CAGR 3-Years
-153%
CAGR 5-Years
-2%
CAGR 10-Years
-17%
Bristol-Myers Squibb Co
NYSE:BMY
Other Items
-$2.8B
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
-14%
Pfizer Inc
NYSE:PFE
Other Items
$1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Other Items
-$9.6B
CAGR 3-Years
-156%
CAGR 5-Years
-14%
CAGR 10-Years
-11%
Eli Lilly and Co
NYSE:LLY
Other Items
-$123m
CAGR 3-Years
46%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Claritas Pharmaceuticals Inc
Glance View

Market Cap
10.4m CAD
Industry
Pharmaceuticals

Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. The company is headquartered in Novato, California. The company went IPO on 2005-05-19. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The firm has leased a laboratory, office, and archival space in Beverly, Massachusetts.

CLAS Intrinsic Value
Not Available
C

See Also

What is Claritas Pharmaceuticals Inc's Other Items?
Other Items
2k USD

Based on the financial report for Dec 31, 2020, Claritas Pharmaceuticals Inc's Other Items amounts to 2k USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett